As Life Science PR experts, TALA joined global leaders in biotech in San Diego for Advanced Therapies Week 2026, our first show for our new client Phacilitate, having become part of their pioneering mission around the advancement of cell and gene therapies.
Aaron Pearson from our international network was on the ground, hosting media and gathering fascinating insights from the conversations that will shape the future of advanced therapies.
Now in its 22nd year, the event once again proved its value as a hub for connection and innovation, and this year’s discussions signalled a clear shift across the industry: the science is advancing rapidly, with growing focus on the operational, regulatory and funding frameworks needed to deliver therapies at scale.
Key themes from the week:
- In vivo therapies are moving centre stage, bringing point-of-care manufacturing into sharper focus.
- New technologies are tackling manufacturing complexity and supporting clinical development.
- Alternative funding routes are opening new pathways for biotech growth.
- Greater regulatory transparency is helping accelerate progress across global markets.
Congratulations to Phacilitate and the entire Advanced Therapies Week team for delivering such a standout gathering for the global advanced therapies community.